TCMD - Tactile Systems Technology Inc Stock Price, Fair Value and News

$17.05-0.18 (-1.04%)

Delayed as of 30 Dec 2024, 12:42 pm ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

TCMD Price Action

Last 7 days

1.4%

Last 30 days

-9.0%

Last 90 days

21.2%

Trailing 12 Months

18.2%

TCMD RSI Chart

TCMD Valuation

Market Cap

413.5M

Price/Earnings (Trailing)

26.77

Price/Sales (Trailing)

1.45

EV/EBITDA

10.25

Price/Free Cashflow

10.38

TCMD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

TCMD Fundamentals

TCMD Revenue

Revenue (TTM)

285.1M

Rev. Growth (Yr)

5.04%

Rev. Growth (Qtr)

-0.17%

TCMD Earnings

Earnings (TTM)

15.4M

Earnings Growth (Yr)

-76.88%

Earnings Growth (Qtr)

19.94%

TCMD Profitability

Operating Margin

73.08%

EBT Margin

7.81%

Return on Equity

7.43%

Return on Assets

5.37%

Free Cashflow Yield

9.64%

TCMD Investor Care

Shares Dilution (1Y)

2.13%

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	276.7M	281.5M	285.1M	0
2023	257.7M	266.3M	270.7M	274.4M
2022	213.3M	221.8M	234.6M	246.8M
2021	186.2M	202.2M	205.6M	208.1M
2020	195.6M	185.5M	184.9M	187.1M
2019	154.5M	165.6M	178.9M	189.5M
2018	116.3M	124.2M	132.2M	143.8M
2017	90.7M	97.2M	102.9M	109.3M
2016	66.5M	71.4M	77.2M	84.5M
2015	51.5M	55.3M	59.1M	62.9M
2014	0	0	0	47.7M

Get all data in R, Python etc through our Historical Stock Data APIs

About Tactile Systems Technology Inc

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices for the treatment of underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, treatment, and share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest for the treatment of retained pulmonary secretions, such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

CEO	Mr. Daniel L. Reuvers
WEBSITE	tactilemedical.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	982

Tactile Systems Technology Inc Frequently Asked Questions

What is the ticker symbol for Tactile Systems Technology Inc? What does TCMD stand for in stocks?

TCMD is the stock ticker symbol of Tactile Systems Technology Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Tactile Systems Technology Inc (TCMD)?

As of Fri Dec 27 2024, market cap of Tactile Systems Technology Inc is 413.47 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TCMD stock?

You can check TCMD's fair value in chart for subscribers.

Is Tactile Systems Technology Inc a good stock to buy?

The fair value guage provides a quick view whether TCMD is over valued or under valued. Whether Tactile Systems Technology Inc is cheap or expensive depends on the assumptions which impact Tactile Systems Technology Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TCMD.

What is Tactile Systems Technology Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 27 2024, TCMD's PE ratio (Price to Earnings) is 26.77 and Price to Sales (PS) ratio is 1.45. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TCMD PE ratio will change depending on the future growth rate expectations of investors.